Vitamin B12 in health and disease

Nutrients

Volumn 2, Issue 3, 2010, Pages 299-316

  O'Leary, Fiona ^a   Samman, Samir ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Adults; Chronic disease; Nutrition; Physiology

Indexed keywords

ANTICONVULSIVE AGENT; COLCHICINE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METFORMIN; METHYLMALONIC ACID; NITROUS OXIDE; PLACEBO; PROTON PUMP INHIBITOR; PYRIDOXINE; BIOLOGICAL MARKER;

ACHLORHYDRIA; AGING; ALZHEIMER DISEASE; ATROPHIC GASTRITIS; BIOAVAILABILITY; BONE DENSITY; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; CYANOCOBALAMIN DEFICIENCY; DIET SUPPLEMENTATION; DIETARY REFERENCE INTAKE; FOOD DRUG INTERACTION; FRACTURE; FRAIL ELDERLY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ABSORPTION; HUMAN; MALABSORPTION; MALNUTRITION; MEGALOBLASTIC ANEMIA; NEURAL TUBE DEFECT; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PERNICIOUS ANEMIA; PHYSICAL DISABILITY; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK REDUCTION; VEGETARIAN DIET; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ABSORPTION; BLOOD; FEMALE; FOOD; MALE; METABOLISM; NUTRITIONAL REQUIREMENT; PREGNANCY; PREGNANCY COMPLICATION;

ANIMALIA;

ABSORPTION; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; FEMALE; FOOD; HUMANS; MALE; NEURAL TUBE DEFECTS; NUTRITIONAL REQUIREMENTS; OSTEOPOROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 79551617260     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu2030299     Document Type: Review

References (99)

1. Scott, J.M. Bioavailability of vitamin B12. Eur. J. Clin. Nutr. 1997, 51, S49-53.
2. Gibson, R.S. Principles of Nutritional Assessment. 2nd ed.; Oxford University Press: New York, NY, USA, 2005.
3. Food and Nutrition Board: Institute of Medicine, Vitamin B12. In Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline; National Research Council, Ed. National Academy Press: Washington, DC, USA, 1998; pp. 306-356.
4. Carmel, R. Mild transcobalamin I (haptocorrin) deficiency and low serum cobalamin concentrations. Clin. Chem. 2003, 49, 1367-1374.
5. Carmel, R.; Green, R.; Rosenblatt, D.S.; Watkins, D. Update on cobalamin, folate, and homocysteine. Hematology Am. Soc. Hematol. Educ. Program 2003, 62-81.
6. Pfeiffer, C.M.; Caudill, S.P.; Gunter, E.W.; Osterloh, J.; Sampson, E.J. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am. J. Clin. Nutr. 2005, 82, 442-450.
7. Klee, G.G. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs vitamin B(12) and folate. Clin. Chem. 2000, 46, 1277-1283.
8. Holleland, G.; Schneede, J.; Ueland, P.M.; Lund, P.K.; Refsum, H.; Sandberg, S. Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clin. Chem. 1999, 45, 189-198.
9. Carmel, R.; Sarrai, M. Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies. Curr. Hematol. Rep. 2006, 5, 23-33.
10. Miller, J. W.; Garrod, M.G.; Rockwood, A.L.; Kushnir, M.M.; Allen, L.H.; Haan, M.N.; Green R. Measurement of total vitamin B12 and holotranscobalamin, singly and in combination, in screening for metabolic vitamin B12 deficiency. Clin. Chem. 2006, 52, 278-285.
11. Heyssel, R.M.; Bozian, R.C.; Darby, W.J.; Bell, M.C. Vitamin B12 turnover in man. The assimilation of vitamin B12 from natural foodstuff by man and estimates of minimal daily requirements. Am. J. Clin. Nutr. 1966, 18, 176-184.
12. Dagnelie, P.C.; van Staveren, W.A.; van den Berg, H. Vitamin B-12 from algae appears not to be bioavailable. Am. J. Clin. Nutr. 1991, 53, 695-697.
13. Chanarin, I. The Megaloblastic Anaemias, 2nd ed.; Blackwell Scientific: Oxford, UK, 1979.
14. Adams, J.F.; Ross, S.K.; Mervyn, R.L.; Boddy, K.; King, P. Absorption of cyanocobalamin, coenzyme B12, methylcobalamin, and hydroxycobalamin at different dose levels. Scand. J. Gastroenterol. 1971, 6, 249-252.
15. Berlin, H.; Berlin, R.; Brante, G. Oral treatment of pernicious anamia with high doses of vitamin B12 without intrinsic factor. Acta. Med. Scand. 1968, 184, 247-257.
16. Schneede, J.; Ueland, P.M. Novel and established markers of cobalamin deficiency: complementary or exclusive diagnostic strategies. Semin. Vasc. Med. 2005, 5, 140-155.
17. Carmel, R. How I treat cobalamin (vitamin B12) deficiency. Blood 2008, 112, 2214-2221.
18. Stabler, S.P.; Allen, R.H. Vitamin B12 deficiency as a worldwide problem. Annu. Rev. Nutr. 2004, 24, 299-326.
19. Watanabe, F. Vitamin B12 sources and bioavailability. Exp. Biol. Med. 2007, 232, 1266-1274.
20. Casey, P.J.; Speckman, K.R.; Ebert, F.J.; Hobbs, W.E. Radioisotope dilution technique for determination of vitamin B12 in foods. J. Assoc. Off. Anal. Chem. 1982, 65, 85-88.
21. Blake, C.J. Analytical procedures for water-soluble vitamins in foods and dietary supplements: a review. Anal. Bioanal. Chem. 2007, 389, 63-76.
22. National Health and Medical Research Council, Nutrient Reference Values for Australia and New Zealand. In Department of Health and Ageing, Ed. Australian Government: Canberra, Australia, 2005; pp. 91-96.
23. Doscherholmen, A.; McMahon, J.; Ripley, D. Vitamin B12 absorption from chicken meat. Am. J. Clin. Nutr. 1978, 31, 825-830.
24. Doscherholmen, A.; McMahon, J.; Ripley, D. Vitamin B12 absorption from fish. Proc. Soc. Exp. Biol. Med. 1981, 167, 480-484.
25. Doscherholmen, A.; McMahon, J.; Ripley, D. Vitamin B12 absorption from eggs. Proc. Soc. Exp. Biol. Med. 1975, 149, 987-990.
26. Li, F.; Watkins, D.; Rosenblatt, D.S. Vitamin B12 and birth defects. Mol. Genet. Metab. 2009, 98, 166-172.
27. Thompson, M.D.; Cole, D.E.; Ray, J.G. Vitamin B-12 and neural tube defects: the Canadian experience. Am. J. Clin. Nutr. 2009, 89, 697S-701S.
28. Carmel, R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch. Intern. Med. 1996, 156, 1097-1100.
29. Allen, L.H. How common is vitamin B-12 deficiency? Am. J. Clin. Nutr. 2009, 89, 693S-696S.
30. Valuck, R.J.; Ruscin, J.M. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. J. Clin. Epidemiol. 2004, 57, 422-428.
31. Den Elzen, W.P.; Groeneveld, Y.; De Ruijter, V.; Souverijn, J.H.; Le Cessie, S.; Assendelft, W.J.; Gussekloo, J. Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals. Aliment. Pharmacol. Ther. 2008, 27, 491-497.
32. O'Leary, F.; Wai, J.; Wormold, L.; Flood, V.; Petocz, P.; Samman, S. No effect of Proton Pump Inhibitor (PPI) medications on vitamin B12 status in elderly rehabilitation patients. Is there a dietary component? Asia Pac. J. Clin. Nutr. 2007, 31, S96.
33. Dharmarajan, T.S.; Kanagala, M.R.; Murakonda, P.; Lebelt, A.S.; Norkus, E.P. Do acid- lowering agents affect vitamin B12 status in older adults? J. Am. Med. Dir. Assoc. 2008, 9, 162-167.
34. Filioussi, K.; Bonovas, S.; Katsaros, T. Should we screen diabetic patients using biguanides for megaloblastic anaemia? Aust. Fam. Physician 2003, 32, 383-384.
35. Bauman, W.A.; Shaw, S.; Jayatilleke, E.; Spungen, A.M.; Herbert, V. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care 2000, 23, 1227-1231.
36. Schilling, R.F. Is nitrous oxide a dangerous anesthetic for vitamin B12- deficient subjects? JAMA 1986, 255, 1605-1606.
37. Siniscalchi, A.; Mancuso, F.; Gallelli, L.; Ferreri, I.; Biagio, M.; Sarro, G.D. Increase in plasma homocysteine levels induced by drug treatments in neurologic patients. Pharmacol. Res. 2005, 52, 367-375.
38. Liu, S.; West, R.; Randell, E.; Longerich, L.; O'Connor, K.; Scott, H.; Crowley, M.; Lam, A.; Prabhakaran, V.; McCourt, C. A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy Childbirth. 2004, 4, 20.
39. Kirke, P.N.; Molloy, A.M.; Daly, L.E.; Burke, H.; Weir, D.G.; Scott, J.M. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q. J. Med. 1993, 86, 703-708.
40. Zhang, T.; Xin, R.; Gu, X.; Wang, F.; Pei, L.; Lin, L.; Chen, G.; Wu, J.; Zheng, X. Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China. Public Health Nutr. 2009, 12, 680-686.
41. Molloy, A.M.; Kirke, P.N.; Troendle, J.F.; Burke, H.; Sutton, M.; Brody, L.C.; Scott, J.M.; Mills, J.L. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification. Pediatrics 2009, 123, 917-923.
42. Zhang, H.-Y.; Luo, G.-A.; Liang, Q.-L.; Wang, Y.; Yang, H.-H.; Wang, Y.-M.; Zheng, X.-Y.; Song, X.-M.; Chen, G.; Zhang, T.; Wu, J.-X. Neural tube defects and disturbed maternal folateand homocysteine-mediated one-carbon metabolism. Exp. Neurol. 2008, 212, 515-521.
43. Ratan, S.K.; Rattan, K.N.; Pandey, R.M.; Singhal, S.; Kharab, S.; Bala, M.; Singh, V.; Jhanwar, A. Evaluation of the levels of folate, vitamin B12, homocysteine and fluoride in the parents and the affected neonates with neural tube defect and their matched controls. Pediatr. Surg. Int. 2008, 24, 803-808.
44. Ray, J.G.; Wyatt, P.R.; Thompson, M.D.; Vermeulen, M.J.; Meier, C.; Wong, P.-Y.; Farrell, S.A.; Cole, D.E. Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology 2007, 18, 362-366.
45. Gaber, K.R.; Farag, M.K.; Soliman, S.E.; El-Bassyouni, H.T.; El-Kamah, G. Maternal vitamin B12 and the risk of fetal neural tube defects in Egyptian patients. Clin. Lab. 2007, 53, 69-75.
46. Afman, L.A.; Van Der Put, N.M.; Thomas, C.M.; Trijbels, J.M.; Blom, H.J. Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects. Q.J. Med. 2001, 94, 159-166.
47. Suarez, L.; Hendricks, K.; Felkner, M.; Gunter, E. Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann. Epidemiol. 2003, 13, 81-88.
48. Groenen, P.M.; van Rooij, I.A.; Peer, P.G.; Gooskens, R.H.; Zielhuis, G.A.; Steegers-Theunissen, R.P. Marginal maternal vitamin B12 status increases the risk of offspring with spina bifida. Am. J. Obstet. Gynecol. 2004, 191, 11-17.
49. Wilson, A.; Platt, R.; Wu, Q.; Leclerc, D.; Christensen, B.; Yang, H.; Gravel, R.A.; Rozen, R. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol. Genet. Metab. 1999, 67, 317-323.
50. van der Put, N.M.; Thomas, C.M.; Eskes, T.K.; Trijbels, F.J.; Steegers-Theunissen, R.P.; Mariman, E.C.; De Graaf-Hess, A.; Smeitink, J.A.; Blom, H.J. Altered folate and vitamin B12 metabolism in families with spina bifida offspring. Q. J. Med. 1997, 90, 505-510.
51. Adams, M.J., Jr.; Khoury, M.J.; Scanlon, K.S.; Stevenson, R.E.; Knight, G.J.; Haddow, J.E.; Sylvester, G.C.; Cheek, J.E.; Henry, J.P.; Stabler, S.P.; Allen, R.H. Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects. Teratology 1995, 51, 311-317.
52. Moens, A.L.; Vrints, C.J.; Claeys, M.J.; Timmermans, J.P.; Champion, H.C.; Kass, D.A. Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 2008, 294, 1971-1977.
53. Boushey, C.J.; Beresford, S.A.; Omenn, G.S.; Motulsky, A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995, 274, 1049-1057.
54. Homocysteine Studies Collaboration, Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002, 288, 2015-2022.
55. Homocysteine Lowering Trialists' Collaboration, Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am. J. Clin. Nutr. 2005, 82, 806-812.
56. Bazzano, L.A.; Reynolds, K.; Holder, K.N.; He, J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 2006, 296, 2720-2726.
57. Wang, X.; Qin, X.; Demirtas, H.; Li, J.; Mao, G.; Huo, Y.; Sun, N.; Liu, L.; Xu, X. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007, 369, 1876-1882.
58. Potter, K.; Hankey, G.J.; Green, D.J.; Eikelboom, J.; Jamrozik, K.; Arnolda, L.F. The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis. BMC Cardiovasc. Disord. 2008, 8, 24.
59. Ebbing, M.; Bleie, O.; Ueland, P.M.; Nordrehaug, J.E.; Nilsen, D.W.; Vollset, S.E.; Refsum, H.; Pedersen, E.K.; Nygard, O. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 2008, 300, 795-804.
60. Toole, J.F.; Malinow, M.R.; Chambless, L.E.; Spence, J.D.; Pettigrew, L.C.; Howard, V.J.; Sides, E.G.; Wang, C.H.; Stampfer, M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004, 291, 565-575.
61. Lonn, E.; Yusuf, S.; Arnold, M.J.; Sheridan, P.; Pogue, J.; Micks, M.; McQueen, M.J.; Probstfield, J.; Fodor, G.; Held, C.; Genest, J., Jr. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 2006, 354, 1567-1577.
62. Bonaa, K.H.; Njolstad, I.; Ueland, P.M.; Schirmer, H.; Tverdal, A.; Steigen, T.; Wang, H.; Nordrehaug, J.E.; Arnesen, E.; Rasmussen, K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med. 2006, 354, 1578-1588.
63. Albert, C.M.; Cook, N.R.; Gaziano, J.M.; Zaharris, E.; MacFadyen, J.; Danielson, E.; Buring, J.E.; Manson, J.E. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 2008, 299, 2027-2036.
64. Zhou, J.; Austin, R.C. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms. Biofactors 2009, 35, 120-129.
65. Antoniades, C.; Antonopoulos, A.S.; Tousoulis, D.; Marinou, K.; Stefanadis, C. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur. Heart J. 2009, 30, 6-15.
66. Righetti, M. Protective effect of vitamin B therapy on bone and cardiovascular disease. Recent Patents Cardiovasc. Drug Discov. 2009, 4, 37-44.
67. Spence, J.D.; Bang, H.; Chambless, L.E.; Stampfer, M.J. Vitamin Intervention For Stroke Prevention trial: an efficacy analysis. Stroke 2005, 36, 2404-2409.
68. Quinlivan, E.P.; McPartlin, J.; McNulty, H.; Ward, M.; Strain, J.J.; Weir, D.G.; Scott, J.M. Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet 2002, 359, 227-228.
69. Spence, J.D. Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol. 2007, 6, 830-838.
70. Smith, A.D.; Refsum, H. Vitamin B-12 and cognition in the elderly. Am. J. Clin. Nutr. 2009, 89, 707S-711S.
71. Lewis, M.S.; Miller, L.S.; Johnson, M.A.; Dolce, E.B.; Allen, R.H.; Stabler, S.P. Elevated methylmalonic acid is related to cognitive impairement in older adults enrolled in an elderly nutrition program. J. Nutr. Elder. 2005, 24, 47-65.
72. Hin, H.; Clarke, R.; Sherliker, P.; Atoyebi, W.; Emmens, K.; Birks, J.; Schneede, J.; Ueland, P.M.; Nexo, E.; Scott, J.; Molloy, A.; Donaghy, M.; Frost, C.; Evans, J.G. Clinical relevance of low serum vitamin B12 concentrations in older people: the Banbury B12 study. Age Ageing 2006, 35, 416-422.
73. Garrod, M.G.; Green, R.; Allen, L.H.; Mungas, D.M.; Jagust, W.J.; Haan, M.N.; Miller, J.W. Fraction of total plasma vitamin B12 bound to transcobalamin correlates with cognitive function in elderly Latinos with depressive symptoms. Clin. Chem. 2008, 54, 1210-1217.
74. Morris, M.S.; Jacques, P.F.; Rosenberg, I.H.; Selhub, J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am. J. Clin. Nutr. 2007, 85, 193-200.
75. Malouf, R.; Areosa Sastre, A., Vitamin B12 for cognition. Cochrane Database Syst. Rev. 2009, 1.
76. Van Dam, F.; Van Gool, W.A. Hyperhomocysteinemia and Alzheimer's disease: A systematic review. Arch. Gerontol. Geriatr. 2009, 48, 425-430.
77. Herrmann, M.; Peter Schmidt, J.; Umanskaya, N.; Wagner, A.; Taban-Shomal, O.; Widmann, T.; Colaianni, G.; Wildemann, B.; Herrmann, W. The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review. Clin. Chem. Lab. Med. 2007, 45, 1621-1632.
78. Herrmann, M.; Umanskaya, N.; Traber, L.; Schmidt-Gayk, H.; Menke, W.; Lanzer, G.; Lenhart M.; Peter Schmidt J.; Herrmann W. The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial. Clin. Chem. Lab. Med. 2007, 45, 1785-1792.
79. Sato, Y.; Honda, Y.; Iwamoto, J.; Kanoko, T.; Satoh, K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 2005, 293, 1082-1088.
80. Green, T.J.; McMahon, J.A.; Skeaff, C.M.; Williams, S.M.; Whiting, S.J. Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial. Am. J. Clin. Nutr. 2007, 85, 460-464.
81. Sawka, A.M.; Ray, J.G.; Yi, Q.; Josse, R.G.; Lonn, E. Randomized clinical trial of homocysteine level lowering therapy and fractures. Arch. Intern. Med. 2007, 167, 2136-2139.
82. Hong, X.; Hsu, Y.-H.; Terwedow, H.; Tang, G.; Liu, X.; Jiang, S.; Xu, X.; Xu, X. Association of the methylenetetrahydrofolate reductase C677T polymorphism and fracture risk in Chinese postmenopausal women. Bone 2007, 40, 737-742.
83. Riancho, J.A.; Valero, C.; Zarrabeitia, M.T. MTHFR polymorphism and bone mineral density: meta-analysis of published studies. Calcif. Tissue Int. 2006, 79, 289-293.
84. Dhonukshe-Rutten, R.A.; Pluijm, S.M.; de Groot, L.C.; Lips, P.; Smit, J.H.; van Staveren, W.A. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J. Bone Miner. Res. 2005, 20, 921-929.
85. McLean, R.R.; Jacques, P.F.; Selhub, J.; Fredman, L.; Tucker, K.L.; Samelson, E.J.; Kiel, D.P.; Cupples, L.A.; Hannan, M.T. Plasma B vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women. J. Clin. Endocrinol. Metab. 2008, 93, 2206-2212.
86. Gjesdal, C.G.; Vollset, S.E.; Ueland, P.M.; Refsum, H.; Meyer, H.E.; Tell, G.S. Plasma homocysteine, folate, and vitamin B12 and the risk of hip fracture: the Hordaland Homocysteine Study. J. Bone Miner. Res. 2007, 22, 747-756.
87. van Meurs, J.B.; Dhonukshe-Rutten, R.A.; Pluijm, S.M.; van der Klift, M.; de Jonge, R.; Lindemans, J.; de Groot, L.C.; Hofman, A.; Witteman, J.C.; van Leeuwen, J.P.; Breteler, M.M.; Lips, P.; Pols, H.A.; Uitterlinden, A.G. Homocysteine levels and the risk of osteoporotic fracture. N. Engl. J. Med. 2004, 350, 2033-2041.
88. Gjesdal, C.G.; Vollset, S.E.; Ueland, P.M.; Refsum, H.; Drevon, C.A.; Gjessing, H.K.; Tell, G.S. Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. Arch. Intern. Med. 2006, 166, 88-94.
89. Tucker, K.L.; Hannan, M.T.; Qiao, N.; Jacques, P.F.; Selhub, J.; Cupples, L.A.; Kiel, D.P. Low plasma vitamin B12 is associated with lower BMD: the Framingham Osteoporosis Study. J. Bone Miner. Res. 2005, 20, 152-158.
90. Morris, M.S.; Jacques, P.F.; Selhub, J. Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 2005, 37, 234-242.
91. Kamburoglu, G.; Gumus, K.; Kadayifcilar, S.; Eldem, B. Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 2005, 1-5.
92. Rochtchina, E.; Wang, J.J.; Flood, V.M.; Mitchell, P. Elevated serum homocysteine, low serum vitamin B12, folate, and age-related macular degeneration: the Blue Mountains Eye Study. Am. J. Ophthalmol. 2007, 143, 344-346.
93. Heuberger, R.A.; Fisher, A.I.; Jacques, P.F.; Klein, R.; Klein, B.E.; Palta, M.; Mares-Perlman, J.A. Relation of blood homocysteine and its nutritional determinants to age-related maculopathy in the third National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 2002, 76, 897-902.
94. Christen, W.G.; Glynn, R.J.; Chew, E.Y.; Albert, C.M.; Manson, J.E. Folic Acid, Pyridoxine, and Cyanocobalamin Combination Treatment and Age-Related Macular Degeneration in Women The Women's Antioxidant and Folic Acid Cardiovascular Study. Arch. Intern. Med. 2009, 169, 335-341.
95. Fried, L.P.; Ferrucci, L.; Darer, J.; Williamson, J.D.; Anderson, G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J. Gerontol. A. Biol. Sci. Med. Sci. 2004, 59, 255-263.
96. Matteini, A.M.; Walston, J.D.; Fallin, M.D.; Bandeen-Roche, K.; Kao, W.H.; Semba, R.D.; Allen, R.H.; Guralnik, J.; Fried, L.P.; Stabler, S.P. Markers of B-vitamin deficiency and frailty in older women. J. Nutr. Health Aging 2008, 12, 303-308.
97. Bartali, B.; Semba, R.D.; Frongillo, E.A.; Varadhan, R.; Ricks, M.O.; Blaum, C.S.; Ferrucci, L.; Guralnik, J.M.; Fried, L.P. Low micronutrient levels as a predictor of incident disability in older women. Arch. Intern. Med. 2006, 166, 2335-2340.
98. O'Leary, F.; Flood, V.; Allman-Farinelli, M.; Petocz, P.; Samman, S. Nutritional status, micronutrient levels and length of stay in an elderly rehabilitation unit. Asia Pac. J. Clin. Nutr. 2009, 33, 106.
99. O'Leary, F.; Wai, J.; Wormald, L.; Ellis, J.; Flood, V.; Petocz, P.; Samman, S. Vitamin B status and length of stay in elderly rehabilitation patients. Nutr. Diet. 2009, 66, A43.